Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Supriya Life says Customs dept initiates judicial proceedings against personnel under Narcotics Act
The company said the proceedings were initiated against Sreedharan under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985 for a procedural lapse for a single export transaction of identified product for which the officer is under judicial detention.
Top picks! Redington among 5 stocks with upside potential of up to 27%. Do you own any?
Monarch Networth Capital has maintained Buy ratings on Pricol, Redington, Sundram Fasteners, Travel Food Services and Viyash Scientific, citing strong earnings growth, improving margins and business expansion. The brokerage sees upside potential of up to 27% across these stocks.
Fortis Healthcare inks pact with Dion Group for 300-bed hospital in Cuttack
Fortis Healthcare is set to manage and operate a new 300-bed multi-specialty hospital in Cuttack, Odisha, a project valued at Rs 600 crore. Developed by Dion Group, the facility aims to significantly enhance access to advanced tertiary care for residents of Cuttack, Bhubaneswar, and surrounding areas. This collaboration merges Fortis's extensive healthcare expertise with Dion's infrastructure development vision, promising quality medical services closer to home.
Inspira seals Rs 1,800-crore private credit for Burger King buy in India
Inspira Global, backed by Ajanta Pharma promoters, is securing ₹1,800 crore in private credit to acquire a controlling stake in India's Burger King operator. The food business, through its arm Lenexis Foodworks, has already raised ₹1,050 crore via NCDs, with the remaining ₹800 crore anticipated this month. This significant funding signals a major move into the quick-service restaurant sector.
FMCG, healthcare in line for strong show in FY27: Brickworks
India's consumer goods and healthcare sectors are poised for robust growth this fiscal year, driven by tax relief, increasing consumer spending, and a booming medical tourism industry. Brickwork Ratings anticipates a significant revenue jump for consumer goods, while healthcare benefits from strong financial health and government initiatives. Most sectors show a stable outlook, with power distribution being the sole exception due to persistent debt issues.
Dalal Street also smokes peace pipe, ends in green for 4th week in row
Indian stock markets concluded their fourth consecutive week of gains, buoyed by declining crude oil prices and improved geopolitical sentiment. Analysts anticipate further upward movement for the Nifty 50, with upcoming quarterly earnings reports expected to guide market direction. Sectoral strength was observed in Realty, Pharma, Healthcare, and Cement, while broader market indices showed mixed performance. Foreign investors were net buyers, contrasting with domestic institutional selling.
Temasek-backed Manipal Health gets approval for India IPO, eyes July listing - The Edge Malaysia
Temasek-backed Manipal Health gets approval for India IPO, eyes July listingThe Edge Malaysia
Why is Bank of Baroda paying $600 million to settle a case?
While the bank has asserted that the settlement was reached without any admission of liability, it has revived allegations by NMC founder B.R. Shetty, who has long accused senior Bank of Baroda officials of colluding with former NMC executives in a fraud that caused the healthcare group’s collapse.
Sun Pharma secures relief in 'Pantocid' trademark dispute
Delhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'Pantocid'. The court permitted Finecure to sell existing stock of 'Pantopacid' within four months, provided an affidavit detailing the inventory is filed. This decision overturns a previous ruling that had refused to grant an injunction against Finecure, highlighting significant sales disparities between the two companies.
Manipal Health gets SEBI approval for up to $1.2 billion IPO, listing likely in late July
Manipal Health Enterprises has secured regulatory approval from the Securities and Exchange Board of India (SEBI) to proceed with its initial public offering, according to sources familiar with the development. The hospital operator is targeting a market debut in late July or early August, subject to prevailing market conditions. The company had filed IPO papers in March to raise up to $1.2 billion, positioning the issue among the largest healthcare listings in India. The planned offering comes at a challenging time for the primary market, with geopolitical tensions and sustained foreign portfolio outflows weighing on investor sentiment. Despite market volatility, the listing is expected to be closely tracked given growing demand for healthcare services and Manipal Health's scale in the hospital sector.
Leo International Precision Health Share Price Today | ETR: LEOW - Investing.com India
Leo International Precision Health Share Price Today | ETR: LEOWInvesting.com India
Pulse of the Street: Realty and healthcare lifts markets, but weak rupee clouds rally
Markets rose nearly 1% this week as softer crude oil prices, easing volatility and buying in real estate, healthcare and consumption stocks lifted sentiment. However, weakness in capital goods and power, along with continued pressure on the rupee, showed that the recovery remained selective